As of Feb 08
| +1.29 / +1.32%|
The 22 analysts offering 12-month price forecasts for Celgene have a median target of 144.00, with a high estimate of 163.00 and a low estimate of 90.00. The median estimate represents a +45.19% increase from the last price of 99.18.
The current consensus among 26 polled investment analysts is to Buy stock in Celgene. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.